Evidence map›Paper›PMID 42807690›Full record

ArticleEJHaem2026

Pediatric Essential Thrombocythemia With a Novel

Kana Tsuji, Suguru Uemura, Tomoko Fujikawa, Nobuyuki Yamamoto, Aiko Kozaki, Atsuro Saito, Toshiaki Ishida, Takeshi Mori, Makiko Yoshida, Takahiro Okutani and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kana TsujiDepartment of Hematology and Oncology Hyogo Prefectural Kobe Children's Hospital Kobe Japan.
Suguru UemuraDepartment of Hematology and Oncology Hyogo Prefectural Kobe Children's Hospital Kobe Japan.ORCID https://orcid.org/0000-0001-7461-9138
Tomoko FujikawaDepartment of Pediatrics Graduate School of Medicine Kobe University Kobe Japan.
Nobuyuki YamamotoDepartment of Pediatrics Graduate School of Medicine Kobe University Kobe Japan.
Aiko KozakiDepartment of Hematology and Oncology Hyogo Prefectural Kobe Children's Hospital Kobe Japan.
Atsuro SaitoDepartment of Hematology and Oncology Hyogo Prefectural Kobe Children's Hospital Kobe Japan.
Toshiaki IshidaDepartment of Hematology and Oncology Hyogo Prefectural Kobe Children's Hospital Kobe Japan.
Takeshi MoriDepartment of Hematology and Oncology Hyogo Prefectural Kobe Children's Hospital Kobe Japan.
Makiko YoshidaDepartment of Pathology Hyogo Prefectural Kobe Children's Hospital Kobe Japan.
Takahiro OkutaniDepartment of Pediatrics Saiseikai Hyogoken Hospital Kobe Japan.
Daiichiro HasegawaDepartment of Hematology and Oncology Hyogo Prefectural Kobe Children's Hospital Kobe Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pediatric essential thrombocythemia (ET) is extremely rare and frequently lacks identifiable driver mutations. We report a case of a 5-year-old male with ET harboring a novel Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.

Indexed as

acquired von Willebrand syndromeanagrelideCALRcase reportessential thrombocythemia

Identifiers

PMID42807690
PMCPMC13619064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.